Biotech Company, Execs Seek Dismissal Of Concocted Securities Fraud Claims
TACOMA, Wash. — Dismissal of shareholder claims in a securities class action against a biotechnology company and three of its senior executives regarding alleged misrepresentations the defendants made about the company’s...To view the full article, register now.
Already a subscriber? Click here to view full article